Fusion glycoprotein F0/F protein (MuV)

Fusion glycoprotein F0/F protein (MuV) Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Mumps virus (1)

  • Tag

    His Tag (1)

  • Conjugate

    Unconjugated (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
RSF-V52H4
Mumps virus
HEK293
Mumps virus (strain Miyahara vaccine) (MuV) Fusion glycoprotein F0, His Tag (MALS verified)
Total: 1
  • 1

Fusion glycoprotein F0/F protein (MuV) Background

The two surface glycoproteins of the mumps virus are the hemagglutinin-neuraminidase (HN) and Fusion proteins. These glycoproteins are essential for viral entry to host cells, and the spread of newly formed virions. The mumps fusion protein (F) is a 538-amino acid, class one fusion surface glycoprotein. It is responsible for the membrane fusion of virus and host cell. The un-cleaved protein has three hydrophobic regions: an amino-terminal signal peptide, an amino terminal region of F1 and the carboxyl-terminal membrane domain. This protein starts as a precursor molecule (F0), and is then cleaved into the active protein by the recognition of a R-X-L/R-R motif by a host endoprotease (furin). The F protein contains two disulfide-linked polypeptides (F1 and F2).

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Anti-FcRL5 CAR-T Cell Therapy(Xuzhou Medical University)Phase 2 ClinicalXuzhou Medical University (Xzmu)Multiple Myeloma
Details
CevostamabRG-6160; BFCR-4350A; RO-7187797Phase 2 ClinicalGenentech IncMultiple Myeloma
Details
  • Product List
  • Clinical Drug Information